Breaking News Instant updates and real-time market news.

GE

General Electric

$8.23

0.17 (2.11%)

, JD

JD.com

$22.28

1.93 (9.48%)

07:35
01/07/19
01/07
07:35
01/07/19
07:35

Unusual call flow in option market yesterday

Notable call activity was cited Friday in General Electric (GE), JD.com (JD), Schlumberger (SLB), Bristol Myers Squibb (BMY), iQiyi (IQ), Macy's (M), Momo (MOMO), Alcoa (AA), Scientific Games (SGMS), and Nexstar (NXST).

GE

General Electric

$8.23

0.17 (2.11%)

JD

JD.com

$22.28

1.93 (9.48%)

SLB

Schlumberger

$39.09

1.45 (3.85%)

BMY

Bristol-Myers

$46.88

1.76 (3.90%)

IQ

iQIYI

$16.25

1.44 (9.72%)

M

Macy's

$29.40

-0.33 (-1.11%)

MOMO

Momo

$25.42

1.39 (5.78%)

AA

Alcoa

$28.33

2.1 (8.01%)

SGMS

Scientific Games

$19.21

1.66 (9.46%)

NXST

Nexstar

$79.88

0.94 (1.19%)

  • 07

    Jan

  • 07

    Jan

  • 10

    Jan

  • 16

    Jan

  • 18

    Jan

  • 24

    Jan

  • 28

    Jan

  • 31

    Jan

  • 10

    Feb

  • 03

    Mar

  • 18

    May

  • 20

    May

GE General Electric
$8.23

0.17 (2.11%)

12/13/18
12/13/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. General Electric (GE) upgraded to Neutral from Underweight at JPMorgan with analyst Stephen Tusa saying he's less negative on the shares with the abating of "known unknowns." 2. Five Below (FIVE) upgraded to Buy from Neutral at Goldman Sachs with analyst Christopher Prykull saying the 18% decline in the stock price over the past month is "disconnected" from the company's robust fundamentals and believes that there is a 20% upside to his price target. 3. Tractor Supply (TSCO) upgraded to Buy from Hold at Deutsche Bank with analyst Michael Baker citing valuation. 4. Procter & Gamble (PG) upgraded to Buy from Neutral at BofA/Merrill with analyst Olivia Tong saying after meetings with CFO Jon Moeller, she believes that the company's early momentum in Q1 of FY19 can be sustained. 5. Dycom (DY) upgraded to Buy from Hold at Craig-Hallum with analyst Christian Schwab saying he believes shares at current levels have become attractive again. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/19/18
VERT
12/19/18
UPGRADE
VERT
Buy
General Electric upgraded to Buy from Hold at Vertical Research
Vertical Research analyst Jeffrey Sprague upgraded General Electric to Buy from Hold with an $11 price target.
12/19/18
12/19/18
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Medtronic (MDT) upgraded to Overweight from Neutral at JPMorgan with analyst Robert Marcus saying that over the past year he's seen a "significant turnaround in performance" at Medtronic. 2. Masimo (MASI) upgraded to Overweight from Neutral at Piper Jaffray with analyst William Quirk saying management, during recent meetings, was upbeat about their near- and longer-term prospects of driving 8%-10% sales growth, at least 100 basis points of operating margin improvement and the company's 30% operating profit goal. 3. Darden (DRI) upgraded to Buy from Hold at Maxim and to Buy from Neutral at BTIG. 4. Best Buy (BBY) upgraded to Neutral, risks priced in, says MoffettNathanson with analyst Greg Melich saying sales and margin risks are reflected in valuation. 5. General Electric (GE) upgraded to Buy from Hold at Vertical Research. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/13/18
JPMS
12/13/18
UPGRADE
Target $6
JPMS
Neutral
General Electric upgraded to Neutral from Underweight at JPMorgan
JPMorgan analyst Stephen Tusa upgraded General Electric to Neutral from Underweight with an unchanged price target of $6. The stock closed yesterday down 5c to $6.71. The analyst says he's less negative on the shares with the abating of "known unknowns." Tusa, however, increasingly assumes a "material equity raise could be necessary." While such an event would create near-term downside in GE shares, there "could be support at a lower level, and likely a benefit of the doubt for new management with a higher multiple on lower earnings" and free cash flow, Tusa tells investors in a research note partially titled "Gonna Walk Before They Make Me Run." The analyst sees a more balanced risk/reward following the recent selloff in General Electric shares.
JD JD.com
$22.28

1.93 (9.48%)

11/20/18
NOMU
11/20/18
DOWNGRADE
Target $24
NOMU
Neutral
JD.com downgraded to Neutral from Buy at Nomura Instinet
Nomura Instinet analyst Jialong Shi downgraded JD.com to Neutral and lowered his price target for the shares to $24 from $41. The analyst says the company provided a "gloomy" outlook when reporting its Q3 results. The midpoint of its Q4 revenue is 1% below the Street estimate, Shi tells investors in a research note.
12/07/18
MKMP
12/07/18
NO CHANGE
Target $35
MKMP
Buy
JD.com price target lowered to $35 from $41 at MKM Partners
MKM Partners analyst Rob Sanderson lowered his price target on JD.com to $35, noting that the company may be increasingly challenged in the short run by the macro backdrop around trade, along with risks around "category exposure" and investment losses. Longer term, the analyst keeps his Buy rating on JD.com however, stating that the stock could see "very significant upside with just decent execution" and triple in value over 3-4 year period.
11/20/18
BNCH
11/20/18
NO CHANGE
Target $31
BNCH
Buy
JD.com price target lowered to $31 from $36 at Benchmark
Benchmark analyst Fawne Jiang noted that JD.com reported Q3 revenue that missed consensus expectations due to macro headwinds, but said that management remains confident that it can continue driving above-industry top-line growth. She expects margins to recover once its heavy investments moderate and keeps her Buy rating on JD.com shares, though Jiang trimmed her price target on the stock to $31 to reflect lower growth estimates and a more conservative margin view.
12/12/18
MZHO
12/12/18
DOWNGRADE
Target $20
MZHO
Neutral
JD.com assumed with a Neutral from Buy at Mizuho
Mizuho Securities analyst James Lee assumed coverage of JD.com with a Neutral rating and $20 price target, down from the firm's prior Buy rating.
SLB Schlumberger
$39.09

1.45 (3.85%)

12/21/18
OTRG
12/21/18
NO CHANGE
OTRG
Pressure Pumping & Completions sector downgraded to Negative at OTR Global
OTR Global downgraded the Pressure Pumping and Completions sector to Negative from Mixed following checks that indicate Major shale E&Ps are lowering 2019 capex plans year-over-year, leading to reduced completion budgets and increasing competition among oilfield service groups.
12/28/18
WELS
12/28/18
NO CHANGE
WELS
Wells sees 'rocky times ahead' for Oil Services and Equipment market
Emerging data points suggest "rocky times ahead" for the North American Oil Services and Equipment market in early 2019, Wells Fargo analyst Judson Bailey tells investors in a research note. As oil prices and macro conditions have weakened to end 2018, a number of recent conversations suggest a "quickly deteriorating" outlook for exploration and production budgets, activity levels and pricing over the first few months of 2019, adds the analyst. He believes the case for "much needed consolidation" across the U.S. oilfield services landscape "has never been greater."
12/19/18
FBCO
12/19/18
DOWNGRADE
FBCO
Neutral
Schlumberger downgraded to Neutral from Outperform at Credit Suisse
12/19/18
12/19/18
DOWNGRADE
Target $44

Neutral
Schlumberger downgraded to Neutral at Credit Suisse
As previously reported, Credit Suisse analyst James Wicklund downgraded Schlumberger to Neutral from Outperform as he updates his sector-wide macro forecasts for a lower expected oil price. In 2019, the analyst sees the overall U.S. rig count declining by about 5%, a 5% decline in completions and a 3% decline in pressure pumping horsepower needed. Wicklund also lowered his price target on the shares to $44 from $65.
BMY Bristol-Myers
$46.88

1.76 (3.90%)

01/04/19
WELS
01/04/19
NO CHANGE
Target $84
WELS
Market Perform
Celgene price target cut to $84 from $90 at Wells Fargo
Wells Fargo analyst Jim Birchenough maintained a Market Perform rating on Celgene (CELG) but cut his price target to $84 following yesterday's proposed acquisition by Bristol-Myers (BMY). In a research note to investors, Birchenough says he continues to see fundamental risk to both Celgene value and deal closing with poor visibility on long-term growth for the combined company and risk to ongoing Revlimid patent litigation. With the debate on Revlimid generic timing and impact likely to remain on overhang, the analyst believes that the proposed acquisition gives greater leverage to generics, reduces the likelihood of a reasonable settlement and complicates any settlement process.
01/04/19
BARD
01/04/19
UPGRADE
Target $92
BARD
Outperform
Baird upgrades Celgene to Outperform, says deal discount looks high
As reported previously, Baird analyst Brian Skorney upgraded Celgene (CELG) to Outperform from Neutral. The analyst believes the current price discount to the Bristol-Myers (BMY) deal price does not makes sense based on the probability of the deal closing in the high $90's. He attributes a 35-40% probability of the deal falling through, but he is more bullish on the deal as management is now shown to be willing sellers. Skorney has a $92 price target on Celgene shares, which are up about 2% in pre-market trading to $82 per share.
01/04/19
EDJN
01/04/19
DOWNGRADE
EDJN
Hold
Bristol-Myers downgraded to Hold from Buy at Edward Jones
01/04/19
01/04/19
DOWNGRADE

Outperform
BeiGene downgraded to Outperform at CLSA as Celgene goes 'from friend to foe'
As previously reported, CLSA analyst David Li downgraded BeiGene to Outperform from Buy following the news yesterday of Bristol-Myers' (BMY) proposed acquisition of Celgene (CELG) in a note titled "From friend to foe." He thinks Celgene is unlikely to continue to cooperate with BeiGene on its PD-1 after the deal goes through and also worries about the three commercialized products licensed from Celgene and about the company selling out of its BeiGene stake, he tells investors. He lowered his price target on BeiGene shares to HK$89.86 from HK$121.34.
IQ iQIYI
$16.25

1.44 (9.72%)

10/29/18
EGHT
10/29/18
UPGRADE
EGHT
Hold
iQIYI upgraded to Hold from Sell at 86 Research
12/12/18
HSBC
12/12/18
INITIATION
Target $22
HSBC
Hold
iQIYI initiated with a Hold at HSBC
HSBC initiated iQIYI with a Hold and $22 price target.
12/12/18
12/12/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Foamix (FOMX) initiated with a Buy at BofA/Merrill. 2. Jazz Pharmaceuticals (JAZZ) initiated with an Outperform at Oppenheimer while GW Pharmaceuticals (GWPH) was initiated with a Perform. 3. Six Flags (SIX) initiated with a Buy at Berenberg. 4. iQIYI (IQ) initiated with a Hold at HSBC. 5. Intercept (ICPT), Viking Therapeutics (VKTX), and Galmed (GLMD) were initiated with a Buy at B. Riley FBR, while Madrigal Pharmaceuticals (MDGL) initiated with a Neutral. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/31/18
FBCO
10/31/18
UPGRADE
FBCO
Outperform
iQIYI upgraded to Outperform from Neutral at Credit Suisse
M Macy's
$29.40

-0.33 (-1.11%)

11/27/18
WEDB
11/27/18
NO CHANGE
WEDB
Macy's, Target among engagement winners during holiday period, says Wedbush
Wedbush analyst Jen Redding notes that the U.S. holiday selling season has started off strong, with winning transactions becoming more important than where they occur, as e-commerce selling surged past expectations.The analyst examined his Campaign Tracker to study key marketing and performance indicators across retailers in the peak holiday selling period. Zara, Free People and Anthropologie (URBN), lululemon (LULU), aerie (AEO), Kohl's (KSS), Macy's (M), and Target (TGT) saw strong engagement for the key holiday period with engagement trends well-above respective sector averages, Redding contends.
11/02/18
CLVD
11/02/18
NO CHANGE
CLVD
Macy's comp trends improved in October, says Cleveland Research
Cleveland Research analyst Rusty Wilson said Neutral rated Macy's owned comp trends appear to have improved in October driven by cold-weather seasonal product. The analyst raised his Q3 owned comp estimate to 2.5% from 2%-2.5%, versus consensus of 2.6%.
12/06/18
12/06/18
DOWNGRADE
Target $28

Underweight
Atlantic says expectations for Macy's too high, downgrades to Underweight
As previously reported, Atlantic Equities analyst Daniela Nedialkova downgraded Macy's to Underweight from Neutral, stating that she sees expectations as too high given that prior year comparisons will be turning tougher for the next several quarters. The past year has been one of recovery, but "2019 may be tougher than 2018," Nedialkova tells investors. Macy's is continuing to execute on its strategic initiatives, which are likely to deliver results, but that improvement will take some time, the analyst added. She lowered her price target on Macy's shares to $28 from $39.
12/06/18
ATLE
12/06/18
DOWNGRADE
ATLE
Underweight
Macy's downgraded to Underweight from Neutral at Atlantic Equities
MOMO Momo
$25.42

1.39 (5.78%)

12/07/18
12/07/18
DOWNGRADE
Target $30

Equal Weight
Morgan Stanley downgrades Momo to Equal Weight, slashes price target to $30
As previously reported, Morgan Stanley analyst Alex Poon downgraded Momo Inc. to Equal Weight from Overweight to reflect the impact of slowing growth at its top customers and threats to its live streaming business. Poon slashed his price target on Momo shares to $30 from $61.
12/07/18
12/07/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Secureworks (SCWX) downgraded to Sector Perform from Outperform at RBC Capital and to Neutral from Outperform at First Analysis. 2. Methanex (MEOH) downgraded to Hold from Buy at Jefferies with analyst Laurence Alexander saying he is now more cautious on the Chemicals space and he expects recession risk signals to continue emerging over the next few quarters. 3. Expeditors (EXPD) downgraded to Sell from Neutral at Goldman Sachs with analyst Matthew Reustle saying he sees "headwinds on the horizon" amid continued deceleration in the company's airfreight business and structural headwinds in its ocean freight business. 4. Chesapeake (CHK) downgraded to Underweight from Neutral at JPMorgan while Devon Energy (DVN) was downgraded to Neutral from Overweight. 5. Momo (MOMO) downgraded to Equal Weight from Overweight at Morgan Stanley and to Neutral from Buy at Citi. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/07/18
NOMU
12/07/18
NO CHANGE
Target $41
NOMU
Buy
Momo price target lowered to $41 from $55 at Nomura Instinet
Nomura Instinet analyst Jialong Shi lowered his price target for Momo to $41 after the the midpoint of the company's Q4 revenue guidance came in 3% below current the consensus. The analyst attributes this to a soft live broadcasting business outlook but keeps a Buy rating on the shares.
12/07/18
SBSH
12/07/18
DOWNGRADE
SBSH
Neutral
Momo downgraded to Neutral from Buy at Citi
AA Alcoa
$28.33

2.1 (8.01%)

10/18/18
BMOC
10/18/18
NO CHANGE
Target $75
BMOC
Outperform
Alcoa remains 'meaningfully undervalued', says BMO Capital
BMO Capital analyst David Gagliano kept his Outperform rating and $75 price target on Alcoa after its Q3 earnings beat and additional $200M stock buyback, maintaining his view that the shares are "meaningfully undervalued" even under the "risk-off" environment assumptions. The analyst notes that the company's earnings beat was driven by its aluminum segment profitability thanks to the strong contributions from energy and flat-rolled products. Gagliano also contends that there is a disconnect between Alcoa valuation multiples typically seen at the peak of the underlying pricing cycle and its compressed marginal cost prices.
10/18/18
FBCO
10/18/18
NO CHANGE
Target $58
FBCO
Outperform
Alcoa too cheap to ignore, says Credit Suisse
Credit Suisse analyst Curt Woodworth believes Alcoa is "significantly undervalued" and thinks the strong operating performance in Q3 and continued tightness in alumina set the stage for meaningful earnings revisions across the Street. The analyst reiterates an Outperform rating and $58 price target on the shares.
10/18/18
JPMS
10/18/18
NO CHANGE
Target $79
JPMS
Overweight
Alcoa price target raised to $79 from $75 at JPMorgan
JPMorgan analyst Michael Gambardella raised his price target for Alcoa to $79 saying the company last night reported a "solid Q3 beat" and continues to operate well in "turbulent" alumina and aluminum markets. With a $200M buyback program announced, the analyst thinks Alcoa will use its cash going forward for repurchases and to continue to reduce its debt and pension obligations. He believes the stock price is "discounting too steep of a drop in alumina and aluminum prices." Gambardella keeps an Overweight rating on Alcoa.
10/09/18
MSCO
10/09/18
NO CHANGE
Target $57
MSCO
Overweight
Alcoa has 10% potential upside if tariffs replaced, says Morgan Stanley
Morgan Stanley analyst Piyush Sood noted that U.S. steel and aluminum tariffs were left in place under the USMCA agreement, but President Trump said they were only being left in place "until such time as we can do something that would be different, like quotas." Replacing U.S. import tariffs on Canadian aluminum with duty-free quotas could add about $150M to Alcoa's annual EBITDA, calculated Sood, who said that equates to about a 10% potential upside in the stock "that the market has so far ignored." The analyst, who sees Alcoa's Q3 results coming in ahead of expectations, keeps an Overweight rating and $57 price target on the shares.
SGMS Scientific Games
$19.21

1.66 (9.46%)

12/14/18
JEFF
12/14/18
NO CHANGE
Target $22
JEFF
Hold
Jefferies sees 'mixed reaction' to Scientific Games shares from settlement
Scientific Games' $151.5M settlement of litigation with Shuffle Tech removes an overhang that has weighed on the stock over the past four months, albeit at the cost of the company's near term financial position and free cash flow generation, Jefferies analyst David Katz tells investors in a research note. Overall, the settlement provides clarity from a range of outcomes, which included the potential for no cash payment, says the analyst. As such. Katz expects a "mixed reaction" in the stock and keeps a Hold rating on Scientific Games with a $22 price target.
11/09/18
CHLM
11/09/18
NO CHANGE
Target $60
CHLM
Buy
Scientific Games selloff 'overdone,' says Craig-Hallum
Craig-Hallum analyst MIke Malouf reiterated a Buy rating and $60 price target following the company's roughly in-line quarter results, telling investors in a research note that he believes the recent selloff in shares is "overdone," as it focuses too closely on Gaming operations and ignores the "vast" potential within the rest of the company.
11/12/18
DBAB
11/12/18
NO CHANGE
Target $26
DBAB
Hold
Scientific Games price target lowered to $26 from $45 at Deutsche Bank
Deutsche Bank analyst Carlo Santarelli lowered his price target for Scientific Games to $26 saying he does not believe there was much in the Q3 print "for investors to be overly excited about." Scientific Games "modestly outpaced" consensus forecasts, with the narrow beat stemming from an end-of-period sale of units from the participation base, Santarelli tells investors in a research note. He continues to see the company "experiencing core operational headwinds" and believes the current valuation is fair. The analyst reaffirms a Hold rating on Scientific Games.
11/16/18
JEFF
11/16/18
DOWNGRADE
Target $22
JEFF
Hold
Scientific Games downgraded to Hold from Buy at Jefferies
Jefferies analyst David Katz downgraded Scientific Games to Hold and cut his price target for the shares to $22 from $46. The changes at the company, some of which are of its own doing and some not, have "compiled to exacerbate the market-driven pressure on the shares," Katz tells investors in a research note. Scientific Games changed CEOs, lost a lawsuit which it expects to appeal, lost a significant systems contract and the high yield market has tightened on higher interest rates, which could mitigate the opportunity to refinance its 10% debt, says the analyst. He believes the pressure from these events is not likely to reverse in the near term. Overhangs, uncertainties and leverage "warrant a more conservative stance," says Katz.
NXST Nexstar
$79.88

0.94 (1.19%)

12/18/18
RILY
12/18/18
NO CHANGE
Target $123
RILY
Buy
Nexstar price target raised to $123 from $92 at B. Riley FBR
B. Riley FBR analyst Barton Crockett raised his price target for Nexstar Media Group (NXST) to $123 saying accretion from the pending Tribune Media (TRCO) is attractive and mitigates any recession risk. The analyst reiterates a Buy rating on the shares.
12/11/18
EVER
12/11/18
UPGRADE
EVER
Outperform
Nexstar upgraded to Outperform from In Line at Evercore ISI
12/07/18
WOLF
12/07/18
INITIATION
Target $112
WOLF
Outperform
Nexstar initiated with an Outperform at Wolfe Research
Wolfe Research initiated Nexstar with an Outperform rating and $112 price target.
12/04/18
BNCH
12/04/18
NO CHANGE
Target $115
BNCH
Buy
Nexstar price target raised to $115 from $96 at Benchmark
Benchmark analyst Daniel Kurnos raised his price target on Nexstar (NXST) to $115 from $96, stating that he believes the company's deal to buy Tribune Media (TRCO) puts Nexstar on track to become the "dominant player in the broadcast space." He sees Nexstar doing all that it takes to consummate the transaction, which in his view will increase the likelihood of a longer-term buyout from private equity, Kurnos tells investors. He maintains a Buy rating on Nexstar shares.

TODAY'S FREE FLY STORIES

GS

Goldman Sachs

$196.91

-0.71 (-0.36%)

08:13
01/24/19
01/24
08:13
01/24/19
08:13
Hot Stocks
Breaking Hot Stocks news story on Goldman Sachs »

Goldman Sachs CEO says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

GS

Goldman Sachs

$196.91

-0.71 (-0.36%)

08:13
01/24/19
01/24
08:13
01/24/19
08:13
Hot Stocks
Goldman Sachs CEO sees 50% chance of 2020 recession »

Sees 15% chance of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

ABM

ABM

$34.61

-0.6 (-1.70%)

08:12
01/24/19
01/24
08:12
01/24/19
08:12
Hot Stocks
ABM water meter replacement project to recoup Sand Diego County district $10M »

ABM has initiated a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YUM

Yum! Brands

$92.76

0.74 (0.80%)

08:12
01/24/19
01/24
08:12
01/24/19
08:12
Hot Stocks
Yum! Brands' KFC announces new global sustainability commitment »

KFC announced a new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

LPCN

Lipocine

$1.56

-0.035 (-2.20%)

08:11
01/24/19
01/24
08:11
01/24/19
08:11
Hot Stocks
Lipocine files IND to evaluate LPCN 1144 in biopsy confirmed NASH subjects »

Lipocine has filed an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GS

Goldman Sachs

$196.91

-0.71 (-0.36%)

08:11
01/24/19
01/24
08:11
01/24/19
08:11
Hot Stocks
Goldman Sachs CEO says 'definitely' in a tightening cycle »

CEO David Solomon is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

EWBC

East West Bancorp

$50.19

0.13 (0.26%)

08:10
01/24/19
01/24
08:10
01/24/19
08:10
Hot Stocks
East West Bancorp sees FY19 NIM between 3.75%-3.8% »

Current outlook for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 12

    Feb

  • 12

    Mar

DLPH

Delphi Technologies

$16.03

-0.23 (-1.41%)

08:09
01/24/19
01/24
08:09
01/24/19
08:09
Hot Stocks
Delphi Technologies announces $200M share repurchase program, suspends dividend »

Delphi Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LKCO

Luokung Technology

$12.01

-1.49 (-11.04%)

08:09
01/24/19
01/24
08:09
01/24/19
08:09
Hot Stocks
Luokung Technology partners with National Engineering Research Center »

Luokung Technology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSTM

Constellium

$8.11

-0.025 (-0.31%)

08:09
01/24/19
01/24
08:09
01/24/19
08:09
Hot Stocks
Constellium to supply aluminum components to Mercedes-Benz »

Constellium announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TXN

Texas Instruments

$95.49

-1.05 (-1.09%)

08:09
01/24/19
01/24
08:09
01/24/19
08:09
Recommendations
Texas Instruments analyst commentary  »

Texas Instruments price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

EWBC

East West Bancorp

$50.19

0.13 (0.26%)

08:08
01/24/19
01/24
08:08
01/24/19
08:08
Earnings
East West Bancorp reports Q4 EPS $1.18, consensus $1.16 »

Reports total loans of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 12

    Feb

  • 12

    Mar

XLNX

Xilinx

$89.55

-0.89 (-0.98%)

08:08
01/24/19
01/24
08:08
01/24/19
08:08
Recommendations
Xilinx analyst commentary  »

Xilinx price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

TSS

TSYS

$87.46

0.49 (0.56%)

08:07
01/24/19
01/24
08:07
01/24/19
08:07
Upgrade
TSYS rating change  »

TSYS upgraded to Neutral,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

UNP

Union Pacific

$154.20

-0.8 (-0.52%)

08:07
01/24/19
01/24
08:07
01/24/19
08:07
Hot Stocks
Union Pacific reports Q4 total revenue carloads up 3% y/y »

Fourth quarter business…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

HFWA

Heritage Financial

$31.13

(0.00%)

08:07
01/24/19
01/24
08:07
01/24/19
08:07
Earnings
Heritage Financial reports Q4 EPS 45c, consensus 50c »

Reports Q4 revenue $,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 12

    Mar

ATU

Actuant

$21.90

-0.15 (-0.68%)

08:07
01/24/19
01/24
08:07
01/24/19
08:07
Hot Stocks
Breaking Hot Stocks news story on Actuant »

Actuant trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRCB

Two River Bancorp

$15.55

-0.06 (-0.38%)

08:06
01/24/19
01/24
08:06
01/24/19
08:06
Hot Stocks
Two River Bancorp announces $2M share repurchase program »

Two River Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MKGAY

Merck KGaA

$0.00

(0.00%)

, VRTX

Vertex

$189.93

-3.88 (-2.00%)

08:05
01/24/19
01/24
08:05
01/24/19
08:05
Hot Stocks
Merck KGaA grants license to Vertex for two DNA damage response inhibitors »

Merck KGaA (MKGAY)…

MKGAY

Merck KGaA

$0.00

(0.00%)

VRTX

Vertex

$189.93

-3.88 (-2.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

  • 11

    Feb

08:05
01/24/19
01/24
08:05
01/24/19
08:05
General news
U.S. initial jobless claims preview: »

U.S. initial jobless…

DDAIF

Daimler AG

$0.00

(0.00%)

, PCAR

Paccar

$61.58

-0.48 (-0.77%)

08:04
01/24/19
01/24
08:04
01/24/19
08:04
Hot Stocks
EU commercial vehicle registrations down 4.0% in November »

In December, commercial…

DDAIF

Daimler AG

$0.00

(0.00%)

PCAR

Paccar

$61.58

-0.48 (-0.77%)

CNHI

CNH Industrial

$9.98

-0.06 (-0.60%)

NAV

Navistar

$30.98

-0.33 (-1.05%)

CMI

Cummins

$143.42

-2.69 (-1.84%)

ALSN

Allison Transmission

$47.81

-0.825 (-1.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

  • 05

    Feb

  • 06

    Feb

  • 06

    Feb

FCX

Freeport McMoRan

$12.30

-0.08 (-0.65%)

08:03
01/24/19
01/24
08:03
01/24/19
08:03
Earnings
Freeport McMoRan reports Q4 adj. EPS 11c, consensus 18c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

FLIR

Flir Systems

$44.69

-0.04 (-0.09%)

08:03
01/24/19
01/24
08:03
01/24/19
08:03
Hot Stocks
Flir Systems awarded $39.6M contract for Black Hornet PRS for U.S. Army »

FLIR Systems has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

  • 11

    Mar

  • 12

    Mar

INGR

Ingredion

$98.16

0.27 (0.28%)

08:03
01/24/19
01/24
08:03
01/24/19
08:03
Downgrade
Ingredion rating change  »

Ingredion downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

  • 12

    Feb

  • 18

    Feb

GWW

Grainger

$297.12

-3.29 (-1.10%)

08:03
01/24/19
01/24
08:03
01/24/19
08:03
Earnings
Grainger sees FY19 EPS $17.10-$18.70, consensus $18.07 »

Sees FY19 revenue growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 07

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.